Intended for healthcare professionals

  1. Research
  2. Comparison of...
  3. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial
CCBYNC Open access
Research

Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial

BMJ 2018; 361 doi: https://doi.org/10.1136/bmj.k2338 (Published 19 June 2018) Cite this as: BMJ 2018;361:k2338 Visual abstract, showing the study population, design and primary outcomes.

Linked editorial

Prostate artery embolisation for benign prostatic hyperplasia

Linked opinion

Prostatic artery embolisation: time to improve collaboration

Related articles

  • No related articles found.
EditorialProstate artery embolisation for benign prostatic hyperplasia
BMJ opinionProstatic artery embolisation: time to improve collaboration

See more

Cited by...

  • In Reply: Surgical and procedural management of benign prostatic hyperplasia
  • 1-year cost-utility analysis of prostate artery embolization (PAE) versus transurethral resection of the prostate (TURP) in benign prostatic hyperplasia (BPH)
  • Efficacy of dexamethasone in reducing the postembolisation syndrome in men undergoing prostatic artery embolisation for benign prostatic hyperplasia: protocol for a single-centre, randomised, double-blind, placebo-controlled trial--the 'DEXAPAE study
  • Contrast enhanced ultrasound (CEUS) with parametric imaging and time intensity curve analysis (TIC) for evaluation of the success of prostate arterial embolization (PAE) in cases of prostate hyperplasia
  • Seeing red after a prostate procedure
Back to top